Laboratory of Medicinal Chemistry, Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, Shido, Sanuki, Kagawa, 769-2193, Japan.
Laboratory of Medicinal Chemistry, Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, Shido, Sanuki, Kagawa, 769-2193, Japan.
J Steroid Biochem Mol Biol. 2019 Mar;187:27-33. doi: 10.1016/j.jsbmb.2018.10.019. Epub 2018 Oct 30.
Two novel 20-hydroxyvitamin D analogues (4a,b) with the A-ring modification have been synthesized by a convergent manner. An alternative pathway of vitamin D metabolism by cytochrome P450scc CYP11A1 was reported to afford 20-hydroxyvitamin D (3), functions of which remain to be explored. Based on the structure of the 20-hydroxy metabolite, novel analogues (4a,b) with the modifications, including the 1α-hydroxy, 25-hydroxy and 2α-methyl groups, have been designed. The side chain of the requisite CD-ring portions (9a,b) was introduced by Grignard reaction as a key step, and the stereochemistry at the C20 position was confirmed by the X-ray crystal structure analysis of the synthetic intermediate (8b). Preliminary biological characterization using the bovine thymus vitamin D receptor suggested that the introduction of the active motifs into the 20-hydroxyvitamin D scaffold elevated the receptor affinity.
两种新型的 A 环修饰的 20-羟基维生素 D 类似物(4a,b)通过汇聚方式合成。细胞色素 P450scc CYP11A1 的维生素 D 代谢的替代途径被报道可以提供 20-羟基维生素 D(3),其功能仍有待探索。基于 20-羟基代谢物的结构,设计了具有修饰的新型类似物(4a,b),包括 1α-羟基、25-羟基和 2α-甲基。所需的 CD-环部分(9a,b)的侧链通过格氏反应引入作为关键步骤,并且通过合成中间体(8b)的 X 射线晶体结构分析确认了 C20 位置的立体化学。使用牛胸腺维生素 D 受体进行的初步生物学表征表明,将活性基序引入 20-羟基维生素 D 支架中提高了受体亲和力。